Virpax Pharmaceuticals Inc Stock

$0.41

20.59% day before yesterday

Nasdaq, Dec 27, 10:19 pm CET

ISIN

US9282511073

Symbol

VRPX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Virpax Pharmaceuticals Inc Stock price

$0.41

-99.59 99.59% 5Y

Nasdaq, Closing price Fri, Dec 27 2024

+0.07 20.59%

ISIN

US9282511073

Symbol

VRPX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Key metrics

Market capitalization	$3.32m
Enterprise Value	$3.30m
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
P/B ratio (TTM) P/B ratio	negative
Revenue (TTM) Revenue	$0.00
EBIT (operating result TTM) EBIT	$-13.37m
Free Cash Flow (TTM) Free Cash Flow	$-16.85m
Cash position	$20.00k
EPS (TTM) EPS	$-8.82
P/E forward	negative
Short interest	7.65%

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Get Started for Free Today

Virpax Pharmaceuticals Inc Stock Analysis

Unlock Scores for Free

??

1 Analyst has issued a forecast Virpax Pharmaceuticals Inc:

1x Buy

100%

More details on Analyst Estimates Including Price Targets

1 Analyst has issued a forecast Virpax Pharmaceuticals Inc:

Buy

100%

Analyst Estimates with Stock Price Targets

Financial data from Virpax Pharmaceuticals Inc

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Sep '24		+/- %
Revenue	- -	- 100%
- Direct Costs	- -	- -
Gross Profit	- -	- -
- Selling and Administrative Expenses	7.56 7.56	24% 24% -
- Research and Development Expense	5.81 5.81	8% 8% -
EBITDA	-13 -13	13% 13% -
- Depreciation and Amortization	- -	- -
EBIT (Operating Income) EBIT	-13 -13	13% 13% -
Net Profit	-13 -13	3% 3% -

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Virpax Pharmaceuticals Inc Stock News

Neutral

Business Wire

●

about one month ago

Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™

BERWYN, Pa.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, today announced results from a minipig Dose Range Finding (“DRF”) study for Probudur. Probudur is the comp...

Neutral

Business Wire

●

about one month ago

Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative

BERWYN, Pa.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing pharmaceutical products for pain management, announced that it has been granted an extension of its cooperative research and development agreement with the National Center for Advancing Translational Sciences (NCATS), an institute/center of the National Ins...

Neutral

GlobeNewsWire

●

about one month ago

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering

New York, NY, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a leading investment banking firm, is pleased to announce its role as the sole placement agent in Virpax Pharmaceuticals, Inc.'s (Nasdaq: VRPX) successful $5.0 million public offering of common stock and pre-funded warrants.

More Virpax Pharmaceuticals Inc News

Company Profile

Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.

Head office	United States
CEO	Jay Dhaliwal
Employees	7
Founded	2016
Website	www.virpaxpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now